RPTX

RPTX

Repare Therapeutics Inc. Common Shares

$1.440+-0.000 (-0.000%)

Reaalajas hind

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$1.440

Kõrge

$1.440

Madal

$1.440

Maht

0.02M

Ettevõtte fundamentaalnäitajad

Kauplemisstatistika

Seotud uudised

BusinessWire

Newly Launched DCx Biotherapeutics In-Licenses Discovery Platforms and Retains Talent and Infrastructure From Repare Therapeutics to Accelerate Development of Multi-Modal Antibody Drug Conjugates

Combines cancer biology, genetics, medicinal chemistry, and biologics research and development experience to rapidly advance a broad pipeline of preclinical oncology programs against genetically-defined

Vaata rohkem
Newly Launched DCx Biotherapeutics In-Licenses Discovery Platforms and Retains Talent and Infrastructure From Repare Therapeutics to Accelerate Development of Multi-Modal Antibody Drug Conjugates
BusinessWire

Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025

Repare Therapeutics Inc. ("Repare" or the "Company") (NASDAQ:RPTX), a leading clinical-stage precision oncology company, today announced the acceptance of two abstracts for mini-oral presentation and the acceptance of

Vaata rohkem
Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025